Insights from in silico exploration of major curcumin analogs targeting human dipeptidyl peptidase IV
The goal of this work is to use a variety of in-silico techniques to identify anti-diabetic agents against DPP-IV enzyme from five main curcumin analogues. To produce the successful molecules, five main curcumin analogues were docked into the active site of DPP-IV enzyme. In comparison to the contro...
Main Authors: | Roney, Miah, Dubey, Amit, Issahaku, Abdul Rashid, Uddin, Md. Nazim, Tufail, Aisha, Wilhelm, Anke, Normaiza, Zamri, Mohd Fadhlizil Fasihi, Mohd Aluwi |
---|---|
Format: | Article |
Language: | English English |
Published: |
Taylor & Francis
2024
|
Subjects: | |
Online Access: | http://umpir.ump.edu.my/id/eprint/41689/1/Insights%20from%20in%20silico%20exploration%20of%20major%20curcumin%20analogs%20targeting%20human%20dipeptidyl.pdf http://umpir.ump.edu.my/id/eprint/41689/2/Insights%20from%20in%20silico%20exploration%20of%20major%20curcumin%20analogs%20targeting%20human%20dipeptidyl%20peptidase%20IV.pdf |
Similar Items
-
Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: In silico approaches
by: Roney, Miah, et al.
Published: (2025) -
Exploration of leads from bis-indole based triazine derivatives targeting human aldose reductase in diabetic type 2: In-silico approaches
by: Roney, Miah, et al.
Published: (2025) -
Inhibitory effect of Sinapic acid derivatives targeting structural and non-structural proteins of dengue virus serotype 2 An in-silico assessment
by: Roney, Miah, et al.
Published: (2023) -
In-silico design of curcumin analogs as potential inhibitors of dengue virus NS2B/NS3 protease
by: Roney, Miah, et al.
Published: (2023) -
Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer
by: Roney, Miah, et al.
Published: (2024)